CD34 and acute myeloid leukemia: Significantly lower expression has been demonstrated for CD34+/CD38− leukemia-initiating cells (LICs) vs. AML bulk cells, but expression was still significantly higher compared to their healthy counterparts (CD34+/CD38− normal hematopoietic stem cells).